Evidence map›Paper›PMID 30383587›Full record

ArticleJournal of acquired immune deficiency syndromes (1999)2018

Effect of TB/HIV Integration on TB and HIV Indicators in Rural Ugandan Health Facilities.

Sarah M Burnett, Stella Zawedde-Muyanja, Sabine M Hermans, Marcia R Weaver, Robert Colebunders, Yukari C Manabe

Open access · greenAbstract read
In one paragraph

Article in Journal of acquired immune deficiency syndromes (1999), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. COVID-19 and malaria: A symptom screening challenge for malaria endemic countries.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2020
    Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 4 countries.

Sarah M BurnettAfricare, Washington, DC.
Stella Zawedde-MuyanjaInfectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
Sabine M HermansInfectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
Marcia R WeaverDepartments of Health Metrics Science and Global Health, University of Washington, Seattle, WA.
Robert ColebundersGlobal Health Institute, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
Yukari C ManabeInfectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
Infectious Diseases Institute · UGAcademic Medical Center · NLAfricare · USUniversity of Antwerp · BEUniversity of Washington · US

Funding

HIV Co-infections in Uganda: TB, Cryptococcus, and Viral Hepatitis.D43TW009771 · FIC · JOHNS HOPKINS UNIVERSITY · PI CASTELNUOVO, BARBARA, KAMBUGU, ANDREW DDUNGU · 2014 to 2023
$3.3M
CGH CDC HHS U01 GH000527FIC NIH HHS D43 TW009771PEPFAR
6 · The paper itself

Abstract

backgroundThe World Health Organization recommends integrating services for patients coinfected with tuberculosis (TB) and HIV. We assessed the effect of TB/HIV integration on antiretroviral therapy (ART) initiation and TB treatment outcomes among TB/HIV-coinfected patients using data collected from 14 rural health facilities during 2 previous TB and HIV quality of care studies.

methodsA facility was considered to have integrated TB/HIV services if patients with TB/HIV had combined treatment for both illnesses by 1 provider or care team at 1 treatment location. We analyzed the effect of integration by conducting a cross-sectional analysis of integrated and nonintegrated facility periods comparing performance on ART initiation and TB treatment outcomes. We conducted logistic regression, with the patient as the unit of analysis, controlling for other intervention effects, adjusting for age and sex, and clustering by health facility.

resultsFrom January 2012 to June 2014, 996 patients with TB were registered, 97% were tested for HIV, and 404 (42%) were HIV-positive. Excluding transfers, 296 patients were eligible for analysis with 117 and 179 from nonintegrated and integrated periods, respectively. Being treated in a facility with TB/HIV integration was associated with lower mortality [adjusted odds ratio (aOR) = 0.38, 95% confidence interval (CI): 0.18 to 0.77], but there was no difference in the proportion initiating ART (aOR = 1.34, 95% CI: 0.40 to 4.47), with TB treatment success (aOR = 1.43, 95% CI: 0.73 to 2.82), lost to follow-up (aOR = 1.64, 95% CI: 0.53 to 5.04), or failure (aOR = 1.21, 95% CI: 0.34 to 4.32).

conclusionsTB/HIV service integration was associated with lower mortality during TB treatment even in settings with suboptimal proportions of patients completing TB treatment and starting on ART.

Indexed as

AdultAnti-HIV AgentsAntitubercular AgentsCoinfectionCross-Sectional StudiesDelivery of Health CareFemaleHealth FacilitiesHIVHIV InfectionsHumansMaleRetrospective StudiesRural PopulationSurvival AnalysisTreatment OutcomeAnti-HIV AgentsAntitubercular Agents

Identifiers

PMID30383587
PMCPMC6422342
OpenAlexW2899407502

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.